Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Influenza

Free Subscription Articles published in PLoS Biol Retrieve available abstracts of 75 articles: HTML format

Single Articles

August 2023
1. LADNER JT, Sahl JW
   Towards a post-pandemic future for global pathogen genome sequencing.
   PLoS Biol. 2023;21:e3002225.
   PubMed     Abstract available
   
   
   
2. LOBINSKA G, Pilpel Y, Nowak MA
   Evolutionary safety of lethal mutagenesis driven by antiviral treatment.
   PLoS Biol. 2023;21:e3002214.
   PubMed     Abstract available
   
   
   
3. KRAFT TS, Seabright E, Alami S, Jenness SM, et al
   Metapopulation dynamics of SARS-CoV-2 transmission in a small-scale Amazonian society.
   PLoS Biol. 2023;21:e3002108.
   PubMed     Abstract available
   
   
   July 2023
4. OLAJIDE OM, Osman MK, Robert J, Kessler S, et al
   Evolutionarily conserved amino acids in MHC-II mediate bat influenza A virus entry into human cells.
   PLoS Biol. 2023;21:e3002182.
   PubMed     Abstract available
   
   
   June 2023
5. STRINE MS, Cai WL, Wei J, Alfajaro MM, et al
   DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner.
   PLoS Biol. 2023;21:e3002097.
   PubMed     Abstract available
   
   
   
6. CHEN NFG, Chaguza C, Gagne L, Doucette M, et al
   Development of an amplicon-based sequencing approach in response to the global emergence of mpox.
   PLoS Biol. 2023;21:e3002151.
   PubMed     Abstract available
   
   
   
7. TSU BV, Agarwal R, Gokhale NS, Kulsuptrakul J, et al
   Host-specific sensing of coronaviruses and picornaviruses by the CARD8 inflammasome.
   PLoS Biol. 2023;21:e3002144.
   PubMed     Abstract available
   
   
   May 2023
8. EALES O, Haw D, Wang H, Atchison C, et al
   Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England.
   PLoS Biol. 2023;21:e3002118.
   PubMed     Abstract available
   
   
   February 2023
9. SIMS A, Tornaletti LB, Jasim S, Pirillo C, et al
   Superinfection exclusion creates spatially distinct influenza virus populations.
   PLoS Biol. 2023;21:e3001941.
   PubMed     Abstract available
   
   
   
10. SHILTS J, Crozier TWM, Teixeira-Silva A, Gabaev I, et al
    LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein.
    PLoS Biol. 2023;21:e3001959.
    PubMed     Abstract available
    
    
    
11. LOO L, Waller MA, Moreno CL, Cole AJ, et al
    Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs.
    PLoS Biol. 2023;21:e3001967.
    PubMed     Abstract available
    
    
    
12. PIELKE R JR
    Improve how science advice is provided to governments by learning from "experts in expert advice".
    PLoS Biol. 2023;21:e3002004.
    PubMed     Abstract available
    
    
    
13. TANG AT, Buchholz DW, Szigety KM, Imbiakha B, et al
    Cell-autonomous requirement for ACE2 across organs in lethal mouse SARS-CoV-2 infection.
    PLoS Biol. 2023;21:e3001989.
    PubMed     Abstract available
    
    
    December 2022
14. BAKER SF, Meistermann H, Tzouros M, Baker A, et al
    Alternative splicing liberates a cryptic cytoplasmic isoform of mitochondrial MECR that antagonizes influenza virus.
    PLoS Biol. 2022;20:e3001934.
    PubMed     Abstract available
    
    
    November 2022
15. MESCI P, de Souza JS, Martin-Sancho L, Macia A, et al
    SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir.
    PLoS Biol. 2022;20:e3001845.
    PubMed     Abstract available
    
    
    
16. GARCIA G JR, Jeyachandran AV, Wang Y, Irudayam JI, et al
    Hippo signaling pathway activation during SARS-CoV-2 infection contributes to host antiviral response.
    PLoS Biol. 2022;20:e3001851.
    PubMed     Abstract available
    
    
    
17. NIEMEYER D, Stenzel S, Veith T, Schroeder S, et al
    SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression.
    PLoS Biol. 2022;20:e3001871.
    PubMed     Abstract available
    
    
    October 2022
18. SONG J, Chow RD, Pena-Hernandez MA, Zhang L, et al
    LRRC15 inhibits SARS-CoV-2 cellular entry in trans.
    PLoS Biol. 2022;20:e3001805.
    PubMed     Abstract available
    
    
    September 2022
19. DAY T, Kennedy DA, Read AF, Gandon S, et al
    Pathogen evolution during vaccination campaigns.
    PLoS Biol. 2022;20:e3001804.
    PubMed     Abstract available
    
    
    
20. CHING KL, de Vries M, Gago J, Dancel-Manning K, et al
    ACE2-containing defensosomes serve as decoys to inhibit SARS-CoV-2 infection.
    PLoS Biol. 2022;20:e3001754.
    PubMed     Abstract available
    
    
    
21. FERNBACH S, Hale BG
    SARS-CoV-2 takes the bait: Exosomes as endogenous decoys.
    PLoS Biol. 2022;20:e3001787.
    PubMed     Abstract available
    
    
    August 2022
22. LIU H, Riggi M, Rogers J, Meyer M, et al
    A new tool for annotating scientific animations and supporting scientific dialogue.
    PLoS Biol. 2022;20:e3001731.
    PubMed     Abstract available
    
    
    
23. ZHU Y, Chew KY, Wu M, Karawita AC, et al
    Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells.
    PLoS Biol. 2022;20:e3001728.
    PubMed     Abstract available
    
    
    July 2022
24. BUSNADIEGO I, Abela IA, Frey PM, Hofmaenner DA, et al
    Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.
    PLoS Biol. 2022;20:e3001709.
    PubMed     Abstract available
    
    
    
25. ROELLE SM, Shukla N, Pham AT, Bruchez AM, et al
    Expanded ACE2 dependencies of diverse SARS-like coronavirus receptor binding domains.
    PLoS Biol. 2022;20:e3001738.
    PubMed     Abstract available
    
    
    June 2022
26. GRIFFIN DE
    Why does viral RNA sometimes persist after recovery from acute infections?
    PLoS Biol. 2022;20:e3001687.
    PubMed     Abstract available
    
    
    
27. TAUBE JC, Miller PB, Drake JM
    An open-access database of infectious disease transmission trees to explore superspreader epidemiology.
    PLoS Biol. 2022;20:e3001685.
    PubMed     Abstract available
    
    
    May 2022
28. ZHU DY, Gorman MJ, Yuan D, Yu J, et al
    Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates.
    PLoS Biol. 2022;20:e3001609.
    PubMed     Abstract available
    
    
    
29. LU-CULLIGAN A, Tabachnikova A, Perez-Then E, Tokuyama M, et al
    No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination.
    PLoS Biol. 2022;20:e3001506.
    PubMed     Abstract available
    
    
    
30. SYENINA A, Gan ES, Toh JZN, de Alwis R, et al
    Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes.
    PLoS Biol. 2022;20:e3001643.
    PubMed     Abstract available
    
    
    
31. RICE BL, Lessler J, McKee C, Metcalf CJE, et al
    Why do some coronaviruses become pandemic threats when others do not?
    PLoS Biol. 2022;20:e3001652.
    PubMed     Abstract available
    
    
    
32. FOLARIN RO, Maina MB, Akinbo AK, Runsewe-Abiodun TI, et al
    Bypassing shortages of personal protective equipment in low-income settings using local production and open source tools.
    PLoS Biol. 2022;20:e3001658.
    PubMed     Abstract available
    
    
    March 2022
33. BESANCON L, Bik E, Heathers J, Meyerowitz-Katz G, et al
    Correction of scientific literature: Too little, too late!
    PLoS Biol. 2022;20:e3001572.
    PubMed     Abstract available
    
    
    
34. JANG KK, Kaczmarek ME, Dallari S, Chen YH, et al
    Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection.
    PLoS Biol. 2022;20:e3001592.
    PubMed     Abstract available
    
    
    February 2022
35. FINCH E, Lowe R, Fischinger S, de St Aubin M, et al
    SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort.
    PLoS Biol. 2022;20:e3001531.
    PubMed     Abstract available
    
    
    
36. BRIERLEY L, Nanni F, Polka JK, Dey G, et al
    Tracking changes between preprint posting and journal publication during a pandemic.
    PLoS Biol. 2022;20:e3001285.
    PubMed     Abstract available
    
    
    December 2021
37. AMANAT F, Strohmeier S, Meade P, Dambrauskas N, et al
    Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus.
    PLoS Biol. 2021;19:e3001384.
    PubMed     Abstract available
    
    
    
38. CASTIGLIONE GM, Zhou L, Xu Z, Neiman Z, et al
    Evolutionary pathways to SARS-CoV-2 resistance are opened and closed by epistasis acting on ACE2.
    PLoS Biol. 2021;19:e3001510.
    PubMed     Abstract available
    
    
    
39. HERDER V, Dee K, Wojtus JK, Epifano I, et al
    Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
    PLoS Biol. 2021;19:e3001065.
    PubMed     Abstract available
    
    
    November 2021
40. MURUATO A, Vu MN, Johnson BA, Davis-Gardner ME, et al
    Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.
    PLoS Biol. 2021;19:e3001284.
    PubMed     Abstract available
    
    
    October 2021
41. SCANLON AO JE
    Wildlife must be protected from crime and trade for the sake of public and planetary health.
    PLoS Biol. 2021;19:e3001422.
    PubMed     Abstract available
    
    
    
42. JACK A, Ferro LS, Trnka MJ, Wehri E, et al
    SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA.
    PLoS Biol. 2021;19:e3001425.
    PubMed     Abstract available
    
    
    September 2021
43. MOLLENTZE N, Babayan SA, Streicker DG
    Identifying and prioritizing potential human-infecting viruses from their genome sequences.
    PLoS Biol. 2021;19:e3001390.
    PubMed     Abstract available
    
    
    August 2021
44. WANG SY, Takahashi T, Pine AB, Damsky WE, et al
    Challenges in interpreting cytokine data in COVID-19 affect patient care and management.
    PLoS Biol. 2021;19:e3001373.
    PubMed     Abstract available
    
    
    July 2021
45. KISSLER SM, Fauver JR, Mack C, Olesen SW, et al
    Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.
    PLoS Biol. 2021;19:e3001333.
    PubMed     Abstract available
    
    
    
46. HOTEZ PJ
    Mounting antiscience aggression in the United States.
    PLoS Biol. 2021;19:e3001369.
    PubMed     Abstract available
    
    
    June 2021
47. HEFFRON AS, McIlwain SJ, Amjadi MF, Baker DA, et al
    The landscape of antibody binding in SARS-CoV-2 infection.
    PLoS Biol. 2021;19:e3001265.
    PubMed     Abstract available
    
    
    
48. NICHOLS JD, Bogich TL, Howerton E, Bjornstad ON, et al
    Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making.
    PLoS Biol. 2021;19:e3001307.
    PubMed     Abstract available
    
    
    May 2021
49. VOGELS CBF, Breban MI, Ott IM, Alpert T, et al
    Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.
    PLoS Biol. 2021;19:e3001236.
    PubMed     Abstract available
    
    
    
50. FU D, Zhang G, Wang Y, Zhang Z, et al
    Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes.
    PLoS Biol. 2021;19:e3001209.
    PubMed     Abstract available
    
    
    
51. LOWE-POWER TM, Dyson L, Polter AM
    A generation of junior faculty is at risk from the impacts of COVID-19.
    PLoS Biol. 2021;19:e3001266.
    PubMed     Abstract available
    
    
    April 2021
52. MOGHADAS SM, Vilches TN, Zhang K, Nourbakhsh S, et al
    Evaluation of COVID-19 vaccination strategies with a delayed second dose.
    PLoS Biol. 2021;19:e3001211.
    PubMed     Abstract available
    
    
    
53. FRASER N, Brierley L, Dey G, Polka JK, et al
    The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape.
    PLoS Biol. 2021;19:e3000959.
    PubMed     Abstract available
    
    
    
54. GALLAGHER T, McCray PB Jr
    The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.
    PLoS Biol. 2021;19:e3001217.
    PubMed     Abstract available
    
    
    
55. ZHU X, Mannar D, Srivastava SS, Berezuk AM, et al
    Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.
    PLoS Biol. 2021;19:e3001237.
    PubMed     Abstract available
    
    
    
56. FERGUSON J, Dunn S, Best A, Mirza J, et al
    Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: Testing frequency and public health messaging is key.
    PLoS Biol. 2021;19:e3001216.
    PubMed     Abstract available
    
    
    March 2021
57. REVERBY SM
    Racism, disease, and vaccine refusal: People of color are dying for access to COVID-19 vaccines.
    PLoS Biol. 2021;19:e3001167.
    PubMed     Abstract available
    
    
    
58. FULWEILER RW, Davies SW, Biddle JF, Burgin AJ, et al
    Rebuild the Academy: Supporting academic mothers during COVID-19 and beyond.
    PLoS Biol. 2021;19:e3001100.
    PubMed     Abstract available
    
    
    
59. KIM KS, Ejima K, Iwanami S, Fujita Y, et al
    A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
    PLoS Biol. 2021;19:e3001128.
    PubMed     Abstract available
    
    
    
60. MACLEAN OA, Lytras S, Weaver S, Singer JB, et al
    Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen.
    PLoS Biol. 2021;19:e3001115.
    PubMed     Abstract available
    
    
    
61. POHL MO, Busnadiego I, Kufner V, Glas I, et al
    SARS-CoV-2 variants reveal features critical for replication in primary human cells.
    PLoS Biol. 2021;19:e3001006.
    PubMed     Abstract available
    
    
    
62. RAVINDRA NG, Alfajaro MM, Gasque V, Huston NC, et al
    Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
    PLoS Biol. 2021;19:e3001143.
    PubMed     Abstract available
    
    
    February 2021
63. RIHN SJ, Merits A, Bakshi S, Turnbull ML, et al
    A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research.
    PLoS Biol. 2021;19:e3001091.
    PubMed     Abstract available
    
    
    
64. COMER SP, Cullivan S, Szklanna PB, Weiss L, et al
    COVID-19 induces a hyperactive phenotype in circulating platelets.
    PLoS Biol. 2021;19:e3001109.
    PubMed     Abstract available
    
    
    January 2021
65. HOTEZ PJ
    Anti-science kills: From Soviet embrace of pseudoscience to accelerated attacks on US biomedicine.
    PLoS Biol. 2021;19:e3001068.
    PubMed     Abstract available
    
    
    December 2020
66. KIM JI, Park S, Bae JY, Lee S, et al
    Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus.
    PLoS Biol. 2020;18:e3001024.
    PubMed     Abstract available
    
    
    
67. REIJNS MAM, Thompson L, Acosta JC, Black HA, et al
    A sensitive and affordable multiplex RT-qPCR assay for SARS-CoV-2 detection.
    PLoS Biol. 2020;18:e3001030.
    PubMed     Abstract available
    
    
    November 2020
68. KENNEDY DA, Read AF
    Monitor for COVID-19 vaccine resistance evolution during clinical trials.
    PLoS Biol. 2020;18:e3001000.
    PubMed     Abstract available
    
    
    
69. ALTHOUSE BM, Wenger EA, Miller JC, Scarpino SV, et al
    Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control.
    PLoS Biol. 2020;18:e3000897.
    PubMed     Abstract available
    
    
    
70. ZHOU Y, Hou Y, Shen J, Mehra R, et al
    A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.
    PLoS Biol. 2020;18:e3000970.
    PubMed     Abstract available
    
    
    
71. KADING RC, Kingston T
    Common ground: The foundation of interdisciplinary research on bat disease emergence.
    PLoS Biol. 2020;18:e3000947.
    PubMed     Abstract available
    
    
    October 2020
72. KUDO E, Israelow B, Vogels CBF, Lu P, et al
    Detection of SARS-CoV-2 RNA by multiplex RT-qPCR.
    PLoS Biol. 2020;18:e3000867.
    PubMed     Abstract available
    
    
    
73. BRUCE EA, Huang ML, Perchetti GA, Tighe S, et al
    Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction step.
    PLoS Biol. 2020;18:e3000896.
    PubMed     Abstract available
    
    
    
74. KUCHARSKI AJ, Funk S, Eggo RM
    The COVID-19 response illustrates that traditional academic reward structures and metrics do not reflect crucial contributions to modern science.
    PLoS Biol. 2020;18:e3000913.
    PubMed     Abstract available
    
    
    September 2020
75. SELZER L, Su Z, Pintilie GD, Chiu W, et al
    Full-length three-dimensional structure of the influenza A virus M1 protein and its organization into a matrix layer.
    PLoS Biol. 2020;18:e3000827.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: